Mannheim, Germany 9/15/15; Cambridgeshire, UK 9/7/15—IVD firm ERBA Diagnostics Mannheim has acquired Lumora, a provider of diagnostic technology for clinical and industrial markets, for an undisclosed amount. “The acquisition of Lumora enhances our existing portfolio of instruments, test kits and reagents for clinical chemistry, microbiology, hematology, diabetes, immunology, urine chemistry, critical care and homeostasis testing,” stated ERBA Chairman and Managing Director Suresh Vazirani. “Lumora has a strong portfolio of molecular technologies which will help us develop molecular testing for emerging country–specific diseases such as HIV and Dengue.”